DNA Methylation and Cancer
Author Information
Author(s): Suzuki M, Shigematsu H, Shames D S, Sunaga N, Takahashi T, Shivapurkar N, Iizasa T, Frenkel E P, Minna J D, Fujisawa T, Gazdar A F
Primary Institution: University of Texas Southwestern Medical Center
Hypothesis
The study examines the role of gene silencing via aberrant methylation of TGFβ-related genes in human cancers.
Conclusion
The study found that TGFβ-related genes DRM/Gremlin, HPP1, and RUNX3 are frequently deregulated through aberrant methylation in many human malignancies.
Supporting Evidence
- DRM/Gremlin mRNA expression was lost in 80% of NSCLC cell lines.
- Methylation of DRM/Gremlin was detected in 73% of NSCLC cell lines.
- Treatment with a methylation inhibitor restored DRM/Gremlin expression in all tested cell lines.
- Methylation of these genes was significantly higher in adult tumors compared to pediatric tumors.
- Methylation of DRM/Gremlin was associated with poorer prognosis in bladder cancer.
Takeaway
Some genes that help control cancer are turned off in many tumors because of a process called methylation, which is like putting a lock on them.
Methodology
The study examined mRNA expression and methylation status of DRM/Gremlin in various cancer cell lines and primary tumors using RT-PCR and methylation-specific PCR.
Potential Biases
Potential bias in sample selection and the limited number of pediatric tumors may affect the findings.
Limitations
The study had a limited number of breast cancer tissues examined and may not be generalizable across all cancer types.
Participant Demographics
The study included various cancer cell lines and primary tumors from adult patients, with some analysis on pediatric tumors.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website